At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,209 enrolled
Drug / intervention
OPTIVE PLUS®drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease
In Brief
An observational study evaluating OPTIVE PLUS® for Dry Eye Syndromes. Completed, enrolled 1,209 participants across 1 site.
Detailed Summary
This is an observational study of OPTIVE PLUS® in patients with dry eye disease in a routine clinical setting. Treatment decisions are made by the physician and reflect the physician's current standard of care.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2012
First PostedOct 2012
Primary CompletionMar 2013
TodayJul 2026
First PostedOct 22, 2012
Enrollment StartSep 1, 2012
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 13.7 years ago
Interventions
OPTIVE PLUS®drug
Patients with dry eye prescribed OPTIVE PLUS® in accordance with physician standard practice.